Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Option and Sells Shares Under 10b5-1 Plan

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on May 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 1, 2024, Marc N. Casper, Chairman and CEO of Thermo Fisher Scientific, exercised stock options to acquire 10,000 shares of common stock at a price of $190.59 per share.
• Simultaneously, Casper sold a total of 8,000 shares of common stock in multiple transactions at weighted average prices ranging from $569.79 to $579.93.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 10, 2023.
• Following these transactions, Casper directly owns 124,816.462 shares of Thermo Fisher Scientific common stock.
• Casper also indirectly owns shares through the Alison Casper 2020 Irrevocable Trust (11,300 shares), Floral Park Associates, Inc. (43,608 shares), and the MNC 2020 Irrevocable Trust (5,000 shares), but disclaims beneficial ownership except to the extent of any pecuniary interest.
• He also holds 26,300 stock options.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates